HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John A Blessing Selected Research

John A Blessing Research Topics

Disease

20Neoplasms (Cancer)
09/2014 - 01/2002
18Carcinoma (Carcinomatosis)
09/2014 - 02/2003
12Endometrial Neoplasms (Endometrial Cancer)
04/2011 - 02/2002
12Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2007 - 04/2002
10Ovarian Neoplasms (Ovarian Cancer)
05/2012 - 01/2002
9Leiomyosarcoma
10/2014 - 01/2002
7Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2012 - 04/2002
6Disease Progression
09/2014 - 09/2003
4Neutropenia
12/2012 - 08/2002
3Ovarian Epithelial Carcinoma
10/2010 - 08/2003
3Carcinosarcoma
08/2010 - 05/2004
3Thrombocytopenia (Thrombopenia)
11/2005 - 04/2003
2Breast Neoplasms (Breast Cancer)
01/2010 - 02/2003
2Adenocarcinoma
08/2005 - 08/2004
1Exanthema (Rash)
03/2008
1Hypersensitivity (Allergy)
03/2008
1Cardiotoxicity
08/2005
1Renal Insufficiency (Renal Failure)
08/2004
1Clinical Deterioration
06/2002

Drug/Important Bio-Agent (IBA)

18PlatinumIBA
12/2012 - 01/2002
12Cisplatin (Platino)FDA LinkGeneric
09/2014 - 04/2002
8GemcitabineFDA Link
10/2014 - 02/2004
7Docetaxel (Taxotere)FDA Link
10/2014 - 02/2003
6Paclitaxel (Taxol)FDA LinkGeneric
07/2009 - 02/2003
5Doxorubicin (Adriamycin)FDA LinkGeneric
06/2008 - 06/2002
4Pemetrexed (MTA)FDA Link
09/2014 - 07/2008
4Topotecan (Hycamtin)FDA LinkGeneric
11/2009 - 12/2002
4NSC 366140 (pyrazoloacridine)IBA
08/2002 - 01/2002
3ixabepilone (BMS 247550)FDA Link
10/2014 - 07/2009
3Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2006 - 07/2003
3liposomal doxorubicin (Doxil)FDA Link
08/2006 - 05/2002
3Vinorelbine (Navelbine)FDA LinkGeneric
01/2005 - 02/2004
2taxaneIBA
10/2014 - 01/2010
2Carboplatin (JM8)FDA LinkGeneric
05/2012 - 03/2008
2irofulvenIBA
10/2010 - 08/2004
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2008 - 06/2008
2Thymidine PhosphorylaseIBA
03/2007 - 03/2005
2Capecitabine (Xeloda)FDA Link
03/2007 - 03/2005
2RNA (Ribonucleic Acid)IBA
03/2007 - 01/2002
2Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
03/2007 - 03/2005
2ParaffinIBA
03/2007 - 03/2005
2AnthracyclinesIBA
08/2006 - 05/2002
2Mitomycin (Mitomycin-C)FDA LinkGeneric
11/2005 - 06/2002
2CreatinineIBA
05/2003 - 04/2003
2Trimetrexate (JB11)FDA Link
05/2002 - 01/2002
1Drug CombinationsIBA
12/2012
1130-nm albumin-bound paclitaxelIBA
12/2012
1Albumin-Bound PaclitaxelFDA Link
12/2012
1acivicin (AT 125)IBA
12/2012
1belinostatIBA
05/2012
1Histone Deacetylase InhibitorsIBA
05/2012
1TrabectedinIBA
01/2012
1epothilone B (EPO906)IBA
01/2010
1Bortezomib (Velcade)FDA Link
11/2009
1Investigational DrugsIBA
07/2009
1Cetuximab (Erbitux)FDA Link
03/2008
1CR 6IBA
03/2008
1ErbB Receptors (EGF Receptor)IBA
03/2008
1Biomarkers (Surrogate Marker)IBA
03/2007
1sargramostim (Leukine)FDA Link
11/2005
1Dacarbazine (DIC)FDA LinkGeneric
11/2005
1alvocidib (flavopiridol)IBA
08/2005
1Thymidylate SynthaseIBA
03/2005
19-aminocamptothecinIBA
01/2005
1ElectrolytesIBA
08/2004
1Irinotecan (Camptosar)FDA LinkGeneric
08/2004
1Platinum Compounds (Compounds, Platinum)IBA
09/2003
1Etoposide (VP 16)FDA LinkGeneric
05/2003
1A 7 (A-7)IBA
05/2003
1BilirubinIBA
04/2003
1A-factor (Streptomyces)IBA
06/2002
11-dodecylpyridoxal (PLD)IBA
05/2002
12-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
05/2002
1IfosfamideFDA LinkGeneric
04/2002
1Bleomycin (Blenoxane)FDA LinkGeneric
04/2002
1DNA (Deoxyribonucleic Acid)IBA
01/2002
1AcridinesIBA
01/2002
19-methoxyacridineIBA
01/2002

Therapy/Procedure

23Therapeutics
10/2014 - 01/2002
21Drug Therapy (Chemotherapy)
01/2012 - 01/2002
2Drug Tapering
12/2012 - 08/2002
1Treatment Delay
11/2005
1Combination Drug Therapy (Combination Chemotherapy)
08/2004